Near future
No Result
View All Result
June 2 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

Experimental device reduces glioblastoma: first human test in the world

A new helmet that generates a non-invasive oscillating magnetic field was able to reduce tumor mass by 31% in a brain cancer patient with glioblastoma.

July 30 2021
Gianluca RiccioGianluca Riccio
⚪ 3 minutes
Share52Pin15Tweet33SendShare9ShareShare7
glioblastoma

READ THIS IN:

Researchers from the neurosurgery department ofHouston Methodist Neurological Institute have reduced a glioblastoma by more than a third. They did this by using a helmet that generates a non-invasive oscillating magnetic field, worn by a patient during home therapy. Unfortunately, the 53-year-old patient died of an unrelated injury about a month after the start of treatment, but already during that first, short period. 31% of the tumor mass disappeared. The autopsy confirmed the rapid response to treatment, and now opens up new scenarios in the treatment of this lethal brain tumor.

Thanks to the courage of this patient and his family, we were able to test and verify the potential effectiveness of the world's first non-invasive therapy against glioblastoma. The generous grant of the autopsy by the family made an invaluable contribution to the further study of this therapy

David S. Baskin, director of the Houston Methodist Department of Neurosurgery and author of the study
glioblastoma
Device helmet with 3 oncoscillators fixed firmly. The oncoscillators are connected to a control box powered by a rechargeable battery. Credits: Houston Methodist

A non-invasive hope against glioblastoma

In the case study published in Frontiers in Oncology, Baskin and his colleagues detailed the pioneering journey of their pioneering patient who suffered from end-stage recurrent glioblastoma, despite radical surgical excision, chemoradiotherapy, and experimental gene therapy.

Glioblastoma is the deadliest of the brain tumors in adults, almost always fatal, with a life expectancy of a few months to two years.

When the patient's glioblastoma recurred in August 2019, Baskin and his team, already working on treatment with mouse models, received FDA approval for compassionate patient treatment with their newly invented oncomagnetic device.

The article continues after the related links

A team of scientists read patients' minds to understand their pain

New studies: a "great leap" made us unique a million years ago

What is the treatment?

The treatment consisted of the intermittent application of an oscillating magnetic field generated by the rotation of permanent magnets in a specific frequency profile and time pattern. First administered for two hours under supervision, subsequent treatments were administered at home with the help of the patient's wife, with treatment times of up to just six hours per day.

The oncomagnetic device looks (apparently) simple: three oncoscillators firmly attached to a helmet and connected to an electronic controller. An invention by the co-author Dr Santosh Helekar. During the five weeks of treatment, magnetic therapy was well tolerated and the mass and volume of the glioblastoma were reduced by nearly a third, with a narrowing that appeared to be related to the treatment dose.

"Imagine treating glioblastoma without radiation or chemotherapy," Baskin said. "Our results in the laboratory and with this patient open up a whole new world of non-invasive and non-toxic therapy for the cancer to the brain, with many interesting possibilities for the future ".

Tags: cancerbraintumors


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Most read of the week

  • Oculus gives VR visit to the Anne Frank house

    267 Shares
    Share 107 Tweet 67
  • Here comes a new magnetic field reversal. We are ready?

    4 Shares
    Share 1 Tweet 1
  • Look what's on my mind: an AI that transforms thoughts into HQ Videos

    4 Shares
    Share 1 Tweet 1
  • Goodbye camera: here is the electronic eye that "sees" like us

    9 Shares
    Share 1 Tweet 1
  • Even the giants "miss": 5 prophecies about the future that are blatantly wrong

    4 Shares
    Share 1 Tweet 1

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok
  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Inland solutions
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Русское издание
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2022 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+